drugset / Trial / NCT02703415

Immune Response of Caudally Administrated Tramadol In Pediatric Lower Abdominal Surgery

NCT02703415

Phase 2 Completed 60 enrolled Assiut University
RandomizedParallel-groupTriple-blindTreatment

Summary

Management of acute pain is one of the most important tasks of perioperative pediatric anesthesia. The alleviation of pain has been defined by the Society of Pediatric Anesthesia, on its 15th annual meeting as a basic human right, irrespective of age, treatment primary service responsible for the patient care. Pro-inflammatory cytokines increased by surgical trauma indirectly modulate pain through the release of substances like nitric oxide, oxygen free radicals, prostaglandins, and excitatory amino acids, inducing peripheral and central sensitivity and hyperalgesia. There has been growing interest in determining the possible immune consequences of analgesic administration for the management of postoperative pain

Timeline

Start
2016-06
Primary completion
2017-08
Completion
2017-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bupivacaine Other / unclassified 0.25 % Other
Comparator Bupivacaine Other / unclassified 1 mg/kg Other
Comparator Tramadol Other / unclassified 1 mg/kg Other

Indications

No indication recorded.